Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection

NCT07672496 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

165

Enrollment

OTHER

Sponsor class

Conditions

Complicated Intra-abdominal Infection (cIAI)
Systemic Inflammatory Response
Sepsis
Immune Dysfunction

Interventions

DRUG: ulinastatin
DRUG: Normal Saline (0.9% NaCl)

Sponsor

Fujian Medical University Union Hospital